Doctors may soon be able to detect and monitor a patient’s cancer with a simple blood test, reducing or eliminating the need for more invasive procedures, according to Purdue University research.
W. Andy Tao, a professor of biochemistry and member of the Purdue University Center for Cancer Research and colleagues identified a series of proteins in blood plasma that, when elevated, signify that the patient has cancer. Their findings were published in the early edition of the Proceedings of the National Academy of Sciences.
Tao’s work was done with samples from breast cancer patients, but it is possible the method could work for any type of cancer and other types of diseases. The work relies on analysis of microvesicles and exosomes in blood plasma.
Protein phosphorylation, the addition of a phosphate group to a protein can lead to cancer cell formation. So phosphorylated proteins, known as phosphoproteins, have been seen as prime candidates for cancer biomarkers. Until now, however, scientists weren’t sure identification of phosphoproteins in blood was possible because the liver releases phosphatase into the bloodstream, which dephosphorylates proteins.
“There are so many types of cancer, even multiple forms for different types of cancer, that finding biomarkers has been discouraging,” Tao said. “This is definitely a breakthrough, showing the feasibility of using phosphoproteins in blood for detecting and monitoring diseases.”
Tao and his colleagues found nearly 2,400 phosphoproteins in a blood sample and identified 144 that were significantly elevated in cancer patients. The study compared 1-milliliter blood samples from 30 breast cancer patients with six healthy controls.
The researchers used centrifuges to separate plasma from red blood cells, and high-speed and ultra-high-speed centrifuges to further separate microvesicles and exosomes. Those particles, which are released from cells and enter the bloodstream, may play a role in intercellular communication and are thought to be involved in metastasis, spreading cancer from one place to another in the body. They also encapsulate phosphoproteins, which Tao’s team identified using mass spectrometry.
“Extracellular vesicles, which include exosomes and microvesicles, are membrane-encapsulated. They are stable, which is important,” Tao said. “The samples we used were 5 years old, and we were still able to identify phosphoproteins, suggesting this is a viable method for identifying disease biomarkers.”
A simple blood test for cancer would be far less invasive than scopes or biopsies that remove tissue. A doctor could also regularly test a cancer patient’s blood to understand the effectiveness of treatment and monitor patients after treatment to see if the cancer is returning.
“There is currently almost no way to monitor patients after treatment,” Tao said. “Doctors have to wait until cancer comes back.”
“The vesicles and exosomes are present and released by all cancers, so it could be that there are general patterns for cancer tissues, but it’s more likely that Andy will develop patterns associated with different cancers. It’s really exciting,” Ratliff said. “Early detection in cancer is key and has been shown to clearly reduce the death rate associated with the disease.”
Tao plans to analyze increased levels of phosphoproteins in various types of cancer to determine whether there are patterns that would signify the type of cancer a patient has. His company, Tymora Analytical, is also developing technology that would allow doctors to insert blood samples onto a cartridge and analyze phosphoproteins present, eliminating the need for ultra-high-speed centrifuges that aren’t practical in clinical settings.
[osd_subscribe categories=’cancer-blood-test’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “CANCER BLOOD TEST”‘]
Receive an email update when we add a new CANCER BLOOD TEST article.
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Exai Bio’s RNA-based Liquid Biopsy Platform Delivers Promising Data on Detecting Breast Cancer at its Earliest Stageson December 6, 2022 at 3:30 pm
Researchers at Exai Bio and UCSF have released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and for the smallest ...
- Kirstie Alley died of colon cancer. Here’s how to lower your riskon December 6, 2022 at 2:54 pm
Colorectal cancer, which includes colon and rectal cancers, is the second most deadly cancer today and is striking more younger people in the prime of their lives. Here's how to use screening to lower ...
- Kirstie Alley died of colon cancer. These are the disease's early signs.on December 6, 2022 at 2:52 pm
Colorectal cancer is the fourth-most common cancer in the U.S. Doctors recommend a colonoscopy every 10 years for people ages 45 and up.
- Kirstie Alley died from colon cancer, a silent disease that usually doesn’t have symptoms until it’s too late. Here’s what you need to knowon December 6, 2022 at 1:31 pm
Actress Kirstie Alley’s death on Monday came as a shock to fans, but in a statement released on Twitter her children shared that the “Cheers” star had been battling cancer albeit “only recently ...
- How genetic testing could help you find breast cancer earlyon December 6, 2022 at 12:00 pm
A blood or saliva sample is used for genetic testing. Doctors are looking for a genetic mutation that increases someone's chances of developing cancer.
- An innovative, noninvasive test could detect cancer in early stageson December 6, 2022 at 8:59 am
In a new study, researchers argue that a noninvasive test checking for tell-tale biomarkers in urine and blood samples could help detect 14 different cancer types in the early stages.
- Colorectal cancer doesn’t wait - DNA methylation tests facilitate earlier treatmenton December 6, 2022 at 8:57 am
In this interview, Yantao Li and Zhe Wang, Director of Cancer Early Screening Products and the Product Director of Oncology at BGI Genomics, talks to NewsMedical about colorectal cancer (CRC), ...
- Woman’s blood cancer misdiagnosed as carpal tunnel due to burning hand painon December 5, 2022 at 11:07 am
A 41-year-old woman was diagnosed with carpal tunnel after experiencing symptoms of burning hand pain, only to discover later that she actually has blood cancer. Roban Lampkin was diagnosed with ...
- Scientists create experimental breath test to detect lung canceron December 5, 2022 at 5:34 am
Recently a group of researchers discovered that patients with lung cancer have a group of 7 volatile organic compounds (VOCs) in their breath, which could help with its detection without CT. Lung ...
via Bing News